Increased adventitial mast cells in a patient with coronary spasm. Forman MB, Oates JA, Robertson D, Robertson RM, Roberts LJ, Virmani R (1985) N Engl J Med 313: 1138-41 Release of prostaglandin D2 into human airways during acute antigen challenge. Murray JJ, Tonnel AB, Brash AR, Roberts LJ, Gosset P, Workman R, Capron A, Oates JA (1986) N Engl J Med 315: 800-4 Increased production of prostaglandin D2 in patients with systemic mastocytosis. Roberts LJ, Sweetman BJ, Lewis RA, Austen KF, Oates JA (1980) N Engl J Med 303: 1400-4 Evidence that histamine is the causative toxin of scombroid-fish poisoning. Morrow JD, Margolies GR, Rowland J, Roberts LJ (1991) N Engl J Med 324: 716-20 Intervention with epinephrine in hypotension associated with mastocytosis. Turk J, Oates JA, Roberts LJ (1983) J Allergy Clin Immunol 71: 189-92 Detection of the major urinary metabolite of prostaglandin D2 in the circulation: demonstration of elevated levels in patients with disorders of systemic mast cell activation. Awad JA, Morrow JD, Roberts LJ (1994) J Allergy Clin Immunol 93: 817-24 Transformation of prostaglandin D2 to 9 alpha, 11 beta-(15S)-trihydroxyprosta-(5Z,13E)-dien-1-oic acid (9 alpha, 11 beta-prostaglandin F2): a unique biologically active prostaglandin produced enzymatically in vivo in humans. Liston TE, Roberts LJ (1985) Proc Natl Acad Sci U S A 82: 6030-4 Isomeric prostaglandin F2 compounds arising from prostaglandin D2: a family of icosanoids produced in vivo in humans. Wendelborn DF, Seibert K, Roberts LJ (1988) Proc Natl Acad Sci U S A 85: 304-8 Stereospecific conversion of prostaglandin D2 to (5Z,13E)-(15S)-9 alpha-11 beta,15-trihydroxyprosta-5,13-dien-1-oic acid (9 alpha,11 beta-prostaglandin F2) and of prostaglandin H2 to prostaglandin F2 alpha by bovine lung prostaglandin F synthase. Watanabe K, Iguchi Y, Iguchi S, Arai Y, Hayaishi O, Roberts LJ (1986) Proc Natl Acad Sci U S A 83: 1583-7 Hazards in operative management of patients with systemic mastocytosis. Scott HW, Parris WC, Sandidge PC, Oates JA, Roberts LJ (1983) Ann Surg 197: 507-14 Increased formation of thromboxane in vivo in humans with mastocytosis. Morrow JD, Oates JA, Roberts LJ, Zackert WE, Mitchell TA, Lazarus G, Guzzo C (1999) J Invest Dermatol 113: 93-7 Improved diagnosis of mastocytosis by measurement of the major urinary metabolite of prostaglandin D2. Morrow JD, Guzzo C, Lazarus G, Oates JA, Roberts LJ (1995) J Invest Dermatol 104: 937-40 New developments in the isoprostane pathway: identification of novel highly reactive gamma-ketoaldehydes (isolevuglandins) and characterization of their protein adducts. Roberts LJ, Salomon RG, Morrow JD, Brame CJ (1999) FASEB J 13: 1157-68 Effects of indomethacin on cyclic nucleotide levels and histamine release from rat serosal mast cells. Lewis RA, Holgate ST, Roberts LJ, Maguire JF, Oates JA, Austen KF (1979) J Immunol 123: 1663-8 Effects of prostaglandin D2 on rat serosal mast cells: discordance between immunologic mediator release and cyclic AMP levels. Holgate ST, Lewis RA, Maguire JF, Roberts LJ, Oates JA, Austen KF (1980) J Immunol 125: 1367-73 Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. Lewis RA, Soter NA, Diamond PT, Austen KF, Oates JA, Roberts LJ (1982) J Immunol 129: 1627-31 Metabolic fate of radiolabeled prostaglandin D2 in a normal human male volunteer. Liston TE, Roberts LJ (1985) J Biol Chem 260: 13172-80 Levuglandinyl adducts of proteins are formed via a prostaglandin H2 synthase-dependent pathway after platelet activation. Boutaud O, Li J, Zagol I, Shipp EA, Davies SS, Roberts LJ, Oates JA (2003) J Biol Chem 278: 16926-8 Renal response to 9 alpha, 11 beta-prostaglandin F2 in the rat. Stier CT, Roberts LJ, Wong PY (1987) J Pharmacol Exp Ther 243: 487-91 Quantification of the major urinary metabolite of prostaglandin D2 by a stable isotope dilution mass spectrometric assay. Morrow JD, Prakash C, Awad JA, Duckworth TA, Zackert WE, Blair IA, Oates JA, Roberts LJ (1991) Anal Biochem 193: 142-8 The flush syndrome: an expression of systemic mastocytosis with increased prostaglandin D2 production. Kootte AM, Haak A, Roberts LJ (1983) Neth J Med 26: 18-20 Quantification of the PGD2 urinary metabolite 9 alpha-hydroxy-11, 15-dioxo-2,3,18,19-tetranorprost-5-ene-1,20-dioic acid by stable isotope dilution mass spectrometric assay. Roberts LJ (1982) Methods Enzymol 86: 559-70
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.